Webjcog1212 「局所進行上顎洞原発扁平上皮癌に対するcddp の超選択的動注と放射線同時併用療法の用 量探索および有効性検証試験」 本研究で用いる医薬品等の製造販売業者等との開示すべき利益相反がある研究者は以下のと おり。 Web7 nov 2024 · Background: We are currently undertaking a multi-institutional prospective trial of the superselective intra-arterial infusion of high-dose cisplatin with concomitant radiotherapy for patients with T4aN0M0 or T4bN0M0 locally advanced maxillary sinus squamous cell carcinomas (SCC). We herein report the results of the dose-finding phase.
IRUCAA@TDC : ホーム
Web臨床研究等提出・公開システム. 臨床研究・治験計画情報の詳細情報です。. JCOG1212: 局所進行上顎洞原発扁平上皮癌に対するCDDPの超選択的動注と放射線同時併用療法の … Weblocally advanced maxillary sinus squamous cell carcinoma (MS-SCC) (JCOG1212, Fig.1) [1]. This study was planned to confirm whether RADPLAT contributes to organ preservation in patients with resectable disease and to afford survival benefits in those with unresectable disease. We herein report the results of the dose-finding phase. flare shutdown
臨床試験登録 - UMIN
Web27 mar 2024 · Background A phase II study of adaptive two-step intensity-modulated radiotherapy (IMRT) with chemotherapy for nasopharyngeal cancer (NPC) (JCOG1015) … Web1 ott 2016 · Superselective intra-arterial infusion of high-dose cisplatin with concomitant radiotherapy (RADPLAT) has been performed for the patients with locally advanced maxillary sinus squamous cell carcinomas (LA-MSSCCs) in several institutions and has been reported to result in a favorable survival. This multi-institutional prospective trial … WebChgIC_JCOG1212_3DRT_170509.docx: 540K : 説明文書・同意書(モデル)[改訂箇所表示付き] IMRT ... can stock photo images be sold on redbubble